CI&T reports its Q1 2026 results on May 13 with short sellers meaningfully more active than they were a month ago — and with analysts still pricing in a stock worth multiples of its current price.
The most striking feature of the setup is the divergence between where the stock trades and where the Street thinks it should be. At $3.99, CINT carries an analyst consensus pointing to 95% upside — a gap wide enough to reflect genuine uncertainty about whether the company can execute a recovery rather than simple analyst optimism. That backdrop is coloured by a deeply oversold RSI of 35, and a stock down 14% over the past month before a 2.6% bounce on Monday. The single confirmed past earnings reaction in the dataset — a +4.6% pop on the day followed by a -3.8% five-day drift after the March 2026 print — shows the market has been quick to fade any relief rallies.
Short interest has risen sharply into this event. Shorts have grown by more than 50% over the past month to 1.8% of the free float — modest in absolute terms but notable for the pace. The borrow market has tightened to match: availability has risen to its 52-week high at 50.7%, meaning roughly one share remains available for every one already borrowed — the tightest the lending pool has been all year. Cost to borrow remains low at 0.63%, down sharply on the week, so while demand for borrows is accelerating, the cost of carrying a short position stays manageable.
The analyst community is constructive but has been trimming targets for months. Wedbush initiated coverage in early April with an Outperform and a $9 target — more than double the current price. UBS and Canaccord both nudged targets slightly higher in March, to $7.10 and $7.00 respectively, after prior cuts. JP Morgan kept its Overweight rating but lowered its target to $6.00 in February. The direction of travel since late 2025 has been downward target revisions on maintained positive ratings — a pattern suggesting the Street believes in the thesis but has repeatedly been wrong on timing. The mean price target across analysts is in the $6–$9 range; at $3.99, the stock trades at a steep discount to even the most conservative of those.
The ownership structure adds an important layer. Three co-founders — Cesar Gon, Fernando Matt Martins, and Bruno Guicardi — collectively hold close to 48% of shares. Advent International controls another 38.5%. With insiders and one sponsor holding roughly 86% of the company between them, the effective float is thin. Recent insider activity was limited to small director award-and-sell transactions around tax obligations — no material buying signal ahead of the print.
The Q1 release tests whether the company's revenue trajectory and margin profile can begin to close the gap between the Street's implied value and the market's current skepticism, or whether persistent macro softness in tech services spending gives bears continued ammunition to press the position.
See the live data behind this article on ORTEX.
Open CINT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
